Bridgeway Capital Management, LLC Alx Oncology Holdings Inc Transaction History

Bridgeway Capital Management, LLC

  • $4.44 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$10.95 - $16.79 $147,825 - $226,665
-13,500 Reduced 40.3%
20,000 $223,000
Q4 2023

Feb 14, 2024
SELL
$4.81 - $15.38 $72,150 - $230,700
-15,000 Reduced 30.93%
33,500 $498,000
Q2 2023

Aug 14, 2023
BUY
$4.37 - $9.56 $211,945 - $463,660
48,500 New
48,500 $364,000

Others Institutions Holding ALXO

# of Institutions
101
Shares Held
39.7M
Call Options Held
134K
Put Options Held
17.4K
View Full List

About ALX ONCOLOGY HOLDINGS INC

ALXO Quotes by TradingView
  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $52.6M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email